Advertisement

Topics

Companies Related to "Study of Chediak-Higashi Syndrome" [Most Relevant Company Matches] - Page: 20 RSS

03:31 EDT 25th March 2019 | BioPortfolio

Here are the most relevant search results for "Study of Chediak-Higashi Syndrome" found in our extensive corporate database of over 50,000 company records.

Showing "Study Chediak Higashi Syndrome" Companies 476–500 of 745

Possibly Relevant

MedTrials, Inc.

Established in 1993, MedTrials has developed into a fully integrated clinical research services firm with full-service capabilities for phase II-IV clinical studies including:Monitoring Auditing Consulting Training Data management Project management Statistical analysis We partner with pharmaceutical, medical device, and biotech companies alike to help get new, groundbreaking products approved and...


Interferon Sciences Incorporated

Interferon Sciences Incorporated is a biopharmaceutical company engaged in the study, manufacture, and sale of pharmaceutical products based on its highly purified, multispecies, natural source alpha interferon ("NaturalAlpha Interferon"). Interferon Sciences' ALFERON N Injection(R) (Interferon Alfa-n3) product has been approved by the United States Food and Drug Administration ("FDA...

Scanadu Inc.

Based at NASA Ames Research Center, Scanadu is using mobile and sensor technology to develop a portfolio of FDA approved, consumer friendly products that put the experience of an emergency room in the palm of your hand. Unveiled in November 2012, the company is working to ensure this is the last generation to know so little about our health. The product po...


Trident Gum

Trident gum has long been a pioneer in providing oral health benefits to consumers. Trident was the first gum brand of its kind to undergo extensive long-term clinical testing in 1967 with studies showing that people who chewed Trident experienced significantly fewer cavities. Most recently, the brand introduced Trident Xtra Care(TM) with Recaldent®, a great tasting sugar free gum that delivers...

RecordAF registry

The RecordAF survey recruited 5,604 patients with recent onset atrial fibrillation from 21 countries spanning North and South America, Europe and Asia (5,171 patients - 92.3 percent were evaluable after 12-month follow-up). They were followed-up for a period of one year. The primary outcomes of the study were therapeutic success and clinical outcomes associated with rhythm- and rate-control st...

WindMIL Therapeutics

When it comes to cell therapy – cell source matters. At WindMIL, we are harnessing the power of bone marrow derived lymphocytes (MILs™) to develop ground-breaking immunotherapies to treat cancer patients. The bone marrow is a natural reservoir of T cells with unique advantages including inherent tumor-specificity. We have perfected an efficient and ...

ZenBio, Inc.

ZenBio, Inc., a privately held biotechnology company, is a leading provider of research tools for the study of human metabolic disease. Founded in 1995, the company performs contract research for major pharmaceutical and biotechnology companies around the world. ZenBio pioneered tissue engineering with adult adipose-derived stem cells and is currently inve...

Stephens & Associates

Stephens & Associates is a contract research organization (CRO) with state-of-the-art technology and full service capabilities to maximize clinical success in all phases of testing for companies developing and manufacturing skin care products including pharmaceuticals, cosmetics, medical devices and personal care. With superior in-house scientific expertis...

Synamem Corporation

Synamem is an early stage biotechnology company which has developed a unique and highly enabling platform for academic and industrial R&D. For the first time, naturally fluid and functional biological membranes have been integrated into a scaleable discovery system, where membrane components retain their natural biological signaling capabilities. It is becoming increasingly evident that spatial r...

Convergence CT

Based in Honolulu, Hawaii, Convergence CT develops and markets highly secure patient data warehouse products, query tools, and patient data research analytics for the pharmaceutical, biotechnology, and healthcare industries. Emphasizing the ‘convergence’ of rich clinical data with advanced information technology and analysis, Convergence CT offers a ...

NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development and commercialization of therapeutic small molecules and recombinant proteins to treat bone and mineral, gastrointestinal and central nervous system disorders. History of Successful Drug Discovery NPS has a history of successful drug discovery. With one approved product on the market and several more in development, NPS's discovery capab...

FACULTY OF SOCIAL AND BEHAVIOURAL SCIENCES

The Faculty of Social and Behavioural Sciences has a prominent standing within the social sciences in Europe and is the largest social science faculty in the Netherlands. It offers a creative study, research and working environment for students, researchers, and staff members. More than 7500 students follow courses within the Faculty. The academic staff work for the educational institutes, the six...

PLC Systems Inc.

PLC Medical Systems, Inc., the operating subsidiary of PLC Systems Inc., is a medical device company focused on innovative technologies for the cardiac and vascular markets. PLC's lead product, RenalGuard®, significantly reduces the onset of CIN in at-risk patients undergoing certain cardiac and vascular imaging procedures. CIN is a form of acute kidney...

Isolagen

Isolagen® Inc., a biotechnology company focused on developing emergent, novel skin and tissue rejuvenation technology for application in certain aesthetic and therapeutic markets. I am pleased to lead Isolagen Inc. as Chairman and Chief Executive Officer. Previously, I served as Chairman, President and CEO of Inamed Corporation, a leading specialty aesthetics company acquired by Allergan Inc. ...

Alizyme Therapeutics Limited

Alizyme is a drug development company. It develops new products to treat diseases with high unmet medical need and substantial market opportunity. To date it has focussed on obesity and related diseases, such as diabetes, and on gastrointestinal disorders including irritable bowel syndrome, inflammatory bowel disease and mucositis, a serious side effect of cancer therapy.Alizyme takes drug product...

ImmunArray

Co-located in Rehovot, Israel and Richmond, Va., ImmunArray is a privately funded molecular diagnostics company dedicated to the development of novel blood-based tests that support the diagnosis and management of complex acute and chronic immune and neurodegenerative diseases. The company designs and analyzes sets of biomarkers known to be linked to a part...

Bavarian Nordic

Bavarian Nordic initiated the development of IMVAMUNE® in 1999 and began the first clinical study in 2001. In 2003, Bavarian Nordic was awarded a contract, valued at $29 million, from the U.S. National Institutes of Health (NIH), for the further development of IMVAMUNE®. In 2004, Bavarian Nordic was awarded its second U.S. Government contract, valued at $115 million, to continue advanced devel...

Ancillare, LP

Ancillare is the only organization of its kind with a singular focus on the global clinical and ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying ...

TransPerfect Trial Interactive

TransPerfect Life Science Solutions provides leading web-based platforms, including eTMFs, that enable sponsors, CROs, IRBs, central laboratories and other vendors to maintain and update clinical trial documentation in a secure online collaborative environment. The Trial Interactive platform enables fully searchable solutions including eTMFs and investigat...

EdOptions

EdOptions(TM) is an award-winning education technology firm located in Arlington, Virginia. Its premier product, Stars Suite(R) (http://www.edoptions.com/products/stars/index.html), has served more than one million students nationwide and features 46 middle and high school courses as well as Web-based solutions for state test preparation, high school preparation and GED study. Other divisions incl...

IC Potash Corp.

IC Potash has previously demonstrated a method to make Sulfate of Potash (“SOP”) from its 100%-owned Ochoa polyhalite deposit in Southeast New Mexico and is currently examining ways to become a low-cost fertilizer producer. The current review of IC Potash’s existing feasibility study is being extended to determine a viable positive economic path...

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through Phase 1 human clinical trials ...

Strongbridge Biopharma plc

Following the successful completion of its exchange offer to acquire the issued ordinary shares of Cortendo AB, Strongbridge Biopharma is now the new parent company of the Cortendo group. The group’s strategic focus is to build a biopharmaceutical company focused on the development, in-licensing, acquisition and eventual commercialization of complemen...

TheraCoat

TheraCoat is a specialty pharmaceutical company founded in 2004 by uro-oncologists and biomaterial specialists. TheraCoat’s Board of Directors and Scientific Advisory Board feature renowned scientific experts in the fields of urology, pharma top executives and experienced business veterans; among them Prof. Belldegrun and Mr. Hurvitz, both TEVA Board ...

HEduBT Secretariat General

The Association seeks to promote degrees in Biotechnology at the Masters and Doctoral levels that acknowledge the exceptional quality of the awardees and have a strongly defined European component. This is by requiring that the student achieves both a deep and broad training through courses in engineering, management, entrepreneurship, computing, economics, international law and biotechnology ethi...


More From BioPortfolio on "Study of Chediak-Higashi Syndrome"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks